The Food and Drug Administration has approved the latest version of Pfizer and BioNTech's COVID-19 vaccine, the companies announced Thursday.

Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

FDA approves updated COVID-19 vaccines for 2026-'27 season, targeting XFG variant. Limited eligibility for adults 65+ and those with high-risk conditions.